SRHHYPOLTD

Sree Rayalaseema Hi-Strength Hypo Limited

Commodity chemicals and wind power generation business

Commodities›Chemicals›Chemicals & Petrochemicals›Commodity Chemicals

srhhl.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹527.85
Market cap
906 Cr
Stock P/E
9.8
P/B
0.93
Dividend yield
0.6%
ROE (FY26)
9.2%
ROCE (FY26)
12.4%
Operating margin (FY26)
12.2%
Debt / equity (FY26)
0.0004
OCF / EBITDA (FY26)
44.3%
OCF / EBITDA (3Y)
83.5%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Sree Rayalaseema Hi-Strength Hypo makes industrial chemicals in India, led by calcium hypochlorite and sulphuric acid, and sells to customers at home and abroad.

Company snapshot

16thBy market cap

Ranked among 24 companies in Commodity Chemicals.

Segment mix

Reportable segments as of 2024-12-31 (Consolidated). Revenue share = segment revenue ÷ total revenue.

Largest segment: 97.1% of revenue

SegmentRevenue shareRevenuePBTAssets
Chemicals
97.1%
463 Cr66 Cr—
Power Generation
1.1%
5 Cr3 Cr—
Trading
1.9%
9 Cr-0.04 Cr—
Unallocated
5.1%
24 Cr24 Cr—

Shares add up to 105% because segment revenues are before inter-segment eliminations.

What we see

Positives
  • ✓Debt-to-equity of 0.00x — the company is largely funded by its own money, not borrowed funds.
1 more signal from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales226 Cr215 Cr165 Cr169 Cr170 Cr138 Cr160 Cr180 Cr182 Cr141 Cr163 Cr211 Cr
Operating expenses (approx.)199 Cr192 Cr138 Cr143 Cr141 Cr119 Cr143 Cr152 Cr155 Cr121 Cr150 Cr181 Cr
EBITDA26 Cr22 Cr27 Cr26 Cr29 Cr20 Cr18 Cr28 Cr27 Cr20 Cr13 Cr30 Cr
OPM %11.6%10.3%16.4%15.2%17.0%14.3%11.0%15.5%14.8%14.4%8.1%14.2%
Other income2 Cr10 Cr9 Cr2 Cr9 Cr13 Cr15 Cr10 Cr7 Cr19 Cr18 Cr10 Cr
Interest0.65 Cr0.62 Cr2 Cr0.61 Cr0.32 Cr0.37 Cr0.69 Cr0.42 Cr0.42 Cr0.41 Cr0.42 Cr0.50 Cr
Depreciation3 Cr3 Cr3 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr
Profit before tax25 Cr23 Cr26 Cr26 Cr36 Cr30 Cr27 Cr31 Cr32 Cr34 Cr23 Cr34 Cr
Tax %27.3%29.1%24.0%28.0%29.4%28.5%19.4%28.5%26.8%30.6%14.4%27.0%
Net profit18 Cr17 Cr20 Cr19 Cr25 Cr22 Cr22 Cr22 Cr23 Cr24 Cr20 Cr25 Cr
EPS (₹)₹10.77₹9.69₹11.39₹10.85₹14.74₹12.56₹12.81₹13.06₹13.57₹14.16₹11.83₹14.53

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales689 Cr911 Cr1,267 Cr1,650 Cr866 Cr638 Cr667 CrSign in free for the trailing twelve months
Operating expenses (approx.)589 Cr781 Cr1,119 Cr1,472 Cr755 Cr546 Cr578 CrSign in free for the trailing twelve months
EBITDA100 Cr130 Cr149 Cr178 Cr111 Cr92 Cr88 CrSign in free for the trailing twelve months
OPM %14.6%14.3%11.7%10.8%12.8%14.4%13.3%Sign in free for the trailing twelve months
Other income4 Cr7 Cr11 Cr34 Cr22 Cr39 Cr55 CrSign in free for the trailing twelve months
Interest9 Cr5 Cr3 Cr2 Cr4 Cr2 Cr2 CrSign in free for the trailing twelve months
Depreciation50 Cr51 Cr19 Cr19 Cr11 Cr7 Cr7 CrSign in free for the trailing twelve months
Profit before tax45 Cr81 Cr137 Cr190 Cr107 Cr119 Cr121 CrSign in free for the trailing twelve months
Tax %16.6%25.1%25.0%19.0%26.4%26.6%25.4%Sign in free for the trailing twelve months
Net profit38 Cr61 Cr103 Cr154 Cr79 Cr87 Cr90 CrSign in free for the trailing twelve months
EPS (₹)₹22.08₹35.29₹59.88₹89.87₹46.01₹50.96₹53.24Sign in free for the trailing twelve months
Dividend payout %—7.1%5.0%3.9%8.7%5.9%5.7%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital17 Cr17 Cr17 Cr17 Cr17 Cr17 Cr17 Cr
Reserves294 Cr371 Cr553 Cr734 Cr783 Cr902 Cr954 Cr
Borrowings40 Cr61 Cr19 Cr12 Cr8 Cr14 Cr0.39 Cr
Other liabilities94 Cr70 Cr198 Cr160 Cr101 Cr122 Cr131 Cr
Total liabilities445 Cr519 Cr788 Cr923 Cr909 Cr1,071 Cr1,115 Cr
Fixed assets (net)138 Cr110 Cr130 Cr102 Cr119 Cr129 Cr87 Cr
CWIP3 Cr0.44 Cr0.05 Cr14 Cr0 Cr0 Cr0 Cr
Investments42 Cr74 Cr164 Cr216 Cr261 Cr357 Cr351 Cr
Loans & advances0.83 Cr0.77 Cr0.97 Cr0.96 Cr26 Cr26 Cr29 Cr
Inventories37 Cr40 Cr144 Cr126 Cr32 Cr40 Cr50 Cr
Trade receivables82 Cr97 Cr132 Cr149 Cr107 Cr103 Cr84 Cr
Cash & bank42 Cr7 Cr14 Cr27 Cr15 Cr369 Cr434 Cr
Other assets101 Cr190 Cr203 Cr288 Cr350 Cr47 Cr80 Cr
Total assets445 Cr519 Cr788 Cr923 Cr909 Cr1,071 Cr1,115 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity99 Cr71 Cr60 Cr141 Cr139 Cr65 Cr39 Cr
Cash from investing-38 Cr-115 Cr-1 Cr-112 Cr-133 Cr-8 Cr37 Cr
Cash from financing-22 Cr10 Cr-51 Cr-17 Cr-17 Cr-17 Cr-11 Cr
Net cash flow40 Cr-35 Cr7 Cr13 Cr-12 Cr40 Cr65 Cr
Free cash flow (OCF − Capex)91 Cr50 Cr45 Cr132 Cr119 Cr63 Cr33 Cr

Ratios

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %15.4%19.2%23.8%25.2%13.8%12.8%12.4%
ROE %12.2%15.6%18.0%20.5%9.9%9.4%9.2%
Debtor days43393833455946
Inventory days394210680294255
Days payable27135745121513
Cash conversion cycle56688768628688
OCF / EBITDA %98.8%54.2%40.2%79.6%125.4%70.8%44.3%
OCF / EBITDA % (3 years)——60.5%59.5%77.8%90.8%83.5%
Debt / equity0.130.160.030.020.010.020.0004
Current ratio2.152.652.353.6610.568.9910.51
Net debt / EBITDA-0.020.420.03-0.08-0.06-3.85-4.90